• Tue, May 8, 2012

by: WOPRAI

MSFG, XTEX, VLNC, OTIV, BPHX, MEA Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

MKS, ARC, EMCI, PMTI, WOLF, MPX Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

ALNY, CTCH, VCBI, CMLS, ABR, DWSN Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

TA, GLCH, NLST, TAST, XHB, RZV Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

CTFO, DHS, DLN, STH, EHTH, HNSN Are Seasonally Ripe To Go Down In the Next Five Weeks

by: WOPRAI

CVCY, AFSI, IHF, HYG, EES, LEI Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

RBCAA, INTU, WCRX, ARB, PJS, GABC Are Seasonally Ripe To Go Up In the Next Five Weeks

by: WOPRAI

CARMIKE CINEMAS INC (NASDAQ:CKEC), Up By 5.50% ($0.77) From $14.010 After BUYINS.NET Report Predicted Strength After Earnings

by: WOPRAI

HUDBAY MINERALS INC (NYSE:HBM), Down By 8.92% ($0.94) From $10.540 After BUYINS.NET Report Predicted Stock Would Go Down Due To

by: WOPRAI

MOTRICITY INC (NASDAQ:MOTR), Down By 24.21% ($0.26) From $1.070 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

CHINA VALVES TECHNOLOGY INC (NASDAQ:CVVT), Down By 10.72% ($0.21) From $1.950 After BUYINS.NET Report Predicted Stock Would Go

by: WOPRAI

CLEAN ENERGY FUELS CORP. (NASDAQ:CLNE), Down By 6.83% ($1.23) From $18.020 After BUYINS.NET Report Predicted Weakness After Ear

by: WOPRAI

Goldex Resources Corp (NYSE:GDX), Down By 6.71% ($3.02) From $45.040 After BUYINS.NET Report Predicted Stock Would Go Down Due

by: WOPRAI

NXSTAGE MEDICAL INC (NASDAQ:NXTM), Down By 5.06% ($0.86) From $17.000 After BUYINS.NET Report Predicted Stock Would Go Down Due

by: WOPRAI

SUPERTEL HOSPITALITY INC (NASDAQ:SPPR), Down By 8.00% ($0.08) From $1.000 After BUYINS.NET Report Predicted Weakness Before Ear

by: WOPRAI

Walter Energy Inc (NYSE:WLT), Down By 5.86% ($3.88) From $66.160 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

K-SWISS INC. (NASDAQ:KSWS), Down By 21.54% ($0.81) From $3.760 After BUYINS.NET Report Predicted Stock Would Go Down Due To Bea

by: WOPRAI

TECUMSEH PRODUCTS CO-CLASS A (NASDAQ:TECUA), Down By 10.77% ($0.39) From $3.620 After BUYINS.NET Report Predicted Weakness Afte

by: WOPRAI

VIVUS INC (NASDAQ:VVUS), Down By 5.49% ($1.30) From $23.680 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

PITNEY BOWES INC (NYSE:PBI), Down By 9.68% ($1.68) From $17.350 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

Desarrolladora Homex SAB de CV (NYSE:HXM), Down By 6.31% ($1.06) From $16.810 After BUYINS.NET Report Predicted Weakness After

by: WOPRAI

DUN & BRADSTREET CORP (NYSE:DNB), Down By 12.39% ($9.53) From $76.940 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

IEC SqueezeTrigger Price is $5.09. There is $87,612 That Short Sellers Still Need To Cover.

by: WOPRAI

ARNA SqueezeTrigger Price is $3.34. There is $93,470,496 That Short Sellers Still Need To Cover.

by: WOPRAI

EPAY SqueezeTrigger Price is $19.07. There is $23,604,372 That Short Sellers Still Need To Cover.

by: WOPRAI

PLPE, Added To Naked Short Lists Today

by: WOPRAI

GRAYMARK HEALTHCARE INC (NASDAQ:GRMH), Up By 11.11% ($0.05) From $0.450 After BUYINS.NET Report Predicted Stock Would Go Up Due

by: WOPRAI

TRANSITION THERAPEUTICS INC (NASDAQ:TTHI), Down By 5.56% ($0.11) From $1.980 After BUYINS.NET Report Predicted Stock Would Go D

by: WOPRAI

TECUMSEH PRODUCTS CO-CLASS A (NASDAQ:TECUA), Down By 5.80% ($0.21) From $3.620 After BUYINS.NET Report Predicted Weakness After

by: WOPRAI

NAUTILUS INC (NYSE:NLS), Down By 11.16% ($0.28) From $2.510 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

FX ENERGY INC (NASDAQ:FXEN), Down By 6.76% ($0.39) From $5.770 After BUYINS.NET Report Predicted Weakness After Earnings

by: WOPRAI

TSLA, LORL, PODD, WSR Expected To Be Up After Next Earnings Releases

by: WOPRAI

PCLN, MIDD, FLT, NP, GCOM, ACHN Expected To Be Up After Next Earnings Releases

by: WOPRAI

ACAT, WWIN Expected To Be Up Before Next Earnings Releases

by: WOPRAI

III, DNN, BIDZ, HTHT Expected To Be Down After Next Earnings Releases

by: WOPRAI

EGLE, RWC, MYRG, QUAD, SCMP, BMTI Expected To Be Down After Next Earnings Releases

by: WOPRAI

SATC, MNKD, GGAL, AIQ, SGMS, ATVI Expected To Be Down After Next Earnings Releases

by: WOPRAI

PRSC, CVO, NNI, CUZ, ENV, WFR Expected To Be Down After Next Earnings Releases

by: WOPRAI

PTNR, STP, ERF, CRYP, GFA Expected To Be Down Before Next Earnings Releases

by: WOPRAI

William Katz Maintained (AB) at Hold and Held Target at $15 on, May 8th, 2012

by: WOPRAI

Michael Feniger Downgraded (ACM) to Sell and Decreased Target to $20 on, May 8th, 2012

by: WOPRAI

Anupam Rama Initiated (ALNY) at Buy and Held Target at $15 on, May 8th, 2012

by: WOPRAI

Michael Wiederhorn Maintained (AMED) at Buy with Increased Target to $16 on, May 8th, 2012

by: WOPRAI

Carlo Santarelli Maintained (WYNN) at Strong Buy with Increased Target to $177 on, May 8th, 2012

by: WOPRAI

Robin Farley Maintained (WYNN) at Strong Buy with Increased Target to $165 on, May 8th, 2012

by: WOPRAI

Matthew Harrison Upgraded (VRTX) to Hold and Increased Target to $51 on, May 8th, 2012

by: WOPRAI

Julien Dumoulin-Smith Maintained (AEE) at Sell with Increased Target to $33 on, May 8th, 2012

by: WOPRAI

John Ivankoe Maintained (SYY) at Hold with Decreased Target to $31 on, May 8th, 2012

Matthew Harrison Upgraded (VRTX) to Hold and Increased Target to $51 on, May 8th, 2012

Matthew Harrison of Morgan Stanley, Upgraded "Vertex Pharmaceuticals Incorporated" (VRTX) to Hold and Increased Target from $28 to $51 on, May 8th, 2012.

Matthew has made no other calls on VRTX in the last 4 months.



There is 1 other peer that has a rating on VRTX. Out of the 1 peers that are also analyzing VRTX, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Ying Huang of "B of A Securities" Maintained at Strong Buy with Increased Target to $49 on, Wednesday, March 14th, 2012